A novel in vitro assay of human islet amyloid polypeptide (hIAPP) amyloidogenesis.

被引:0
|
作者
Kudva, YC [1 ]
Mueske, CS [1 ]
Butler, PC [1 ]
Eberhardt, NL [1 ]
机构
[1] MAYO CLIN,DEPT MED,DIV ENDOCRINOL,ROCHESTER,MN
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:A260 / A260
页数:1
相关论文
共 50 条
  • [41] Human Islet Amyloid Polypeptide (hIAPP) Protofibril-Specific Antibodies for Detection and Treatment of Type 2 Diabetes
    Bortoletto, Angelina S.
    Graham, W. Vallen
    Trout, Gabriella
    Bonito-Oliva, Alessandra
    Kazmi, Manija A.
    Gong, Jing
    Weyburne, Emily
    Houser, Brandy L.
    Sakmar, Thomas P.
    Parchem, Ronald J.
    ADVANCED SCIENCE, 2022, 9 (34)
  • [42] In vitro investigation on the interaction of human islet amyloid polypeptide with model membranes
    Sadasivam, S. Manikam
    Antoinette, K. J.
    EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS, 2013, 42 : S152 - S152
  • [43] Molecular Dynamics Simulations Reveal the Inhibitory Mechanism of Dopamine against Human Islet Amyloid Polypeptide (hIAPP) Aggregation and Its Destabilization Effect on hIAPP Protofibrils
    Lao, Zenghui
    Chen, Yujie
    Tang, Yiming
    Wei, Guanghong
    ACS CHEMICAL NEUROSCIENCE, 2019, 10 (09): : 4151 - 4159
  • [44] In Vitro Interactions Between Amyloid Beta and Islet Amyloid Polypeptide
    Vandiver, Leah
    BIOPHYSICAL JOURNAL, 2014, 106 (02) : 56A - 56A
  • [45] The S20G Human Islet Amyloid Polypeptide (hIAPP) Mutant Is More Amyloidogenic and Cytotoxic than Wild-Type hIAPP in Islets
    Meier, Daniel T.
    Hogan, Meghan F.
    Templin, Andrew T.
    Kahn, Steven E.
    DIABETES, 2015, 64 : A576 - A576
  • [46] Upregulation of the Amyloid-Degrading Enzyme, Neprilysin, Results in Decreased Amyloid and Apoptosis in Islets from Human Islet Amyloid Polypeptide (hIAPP) Transgenic Mice
    Zraika, Sakeneh
    Aston-Mourney, Kathryn
    Hull, Rebecca L.
    Udayasankar, Jayalakshmi
    Subramanian, Shoba L.
    Green, Pattie S.
    Kahn, Steven E.
    DIABETES, 2009, 58 : A407 - A407
  • [47] Rosiglitazone treatment decreases a myloid formation following transplantation of human-islet amyloid polypeptide (hIAPP) transgenic islets
    Udayasankar, Jayalakshmi
    Hull, Rebecca L.
    Zraika, Sakeneh
    Aston-Mourney, Kathryn
    Subramanian, Shoba L.
    Taborsky, Gerald J.
    Kahn, Steven E.
    DIABETES, 2008, 57 : A77 - A77
  • [48] Human islet amyloid polypeptide (hIAPP) - a curse in type II diabetes mellitus: insights from structure and toxicity studies
    Bishoyi, Ajit Kumar
    Roham, Pratiksha H.
    Rachineni, Kavitha
    Save, Shreyada
    Hazari, M. Asrafuddoza
    Sharma, Shilpy
    Kumar, Ashutosh
    BIOLOGICAL CHEMISTRY, 2021, 402 (02) : 133 - 153
  • [49] AGGREGATED HUMAN ISLET AMYLOID POLYPEPTIDE IS NOT CYTOTOXIC TO MOUSE ISLETS IN-VITRO
    CLARK, A
    BADMAN, MK
    LOWNDES, SA
    MORRIS, JF
    DIABETOLOGIA, 1995, 38 : A91 - A91
  • [50] Conformational transitions of islet amyloid polypeptide (IAPP) in amyloid formation in vitro
    Kayed, R
    Bernhagen, J
    Greenfield, N
    Sweimeh, K
    Brunner, H
    Voelter, W
    Kapurniotu, A
    JOURNAL OF MOLECULAR BIOLOGY, 1999, 287 (04) : 781 - 796